Overview
flowchart TD
companies_apdm["APDM Mobility Lab"]
style companies_apdm fill:#4fc3f7,stroke:#333,color:#000
companies_apdm_0["Company History"]
companies_apdm -->|"includes"| companies_apdm_0
style companies_apdm_0 fill:#81c784,stroke:#333,color:#000
companies_apdm_1["Founding and Early Development"]
companies_apdm -->|"includes"| companies_apdm_1
style companies_apdm_1 fill:#ef5350,stroke:#333,color:#000
companies_apdm_2["Movella Acquisition 2022"]
companies_apdm -->|"includes"| companies_apdm_2
style companies_apdm_2 fill:#ffd54f,stroke:#333,color:#000
companies_apdm_3["Products and Technology"]
companies_apdm -->|"includes"| companies_apdm_3
style companies_apdm_3 fill:#ce93d8,stroke:#333,color:#000
companies_apdm_4["Opal Sensors"]
companies_apdm -->|"includes"| companies_apdm_4
style companies_apdm_4 fill:#4fc3f7,stroke:#333,color:#000
companies_apdm_5["Mobility Lab Software"]
companies_apdm -->|"includes"| companies_apdm_5
style companies_apdm_5 fill:#81c784,stroke:#333,color:#000
APDM (Advanced Physical Diagnostic Methods) is a leading provider of wearable sensor systems for movement disorder analysis and clinical gait research. Originally based in Portland, Oregon, the company was acquired by Movella in 2022 and continues to offer its industry-standard mobility assessment platform under the Mobility Lab brand["@mancini2017"].
...Overview
Mermaid diagram (expand to render)
APDM (Advanced Physical Diagnostic Methods) is a leading provider of wearable sensor systems for movement disorder analysis and clinical gait research. Originally based in Portland, Oregon, the company was acquired by Movella in 2022 and continues to offer its industry-standard mobility assessment platform under the Mobility Lab brand["@mancini2017"].
APDM's technology has become a standard in movement disorder research, particularly for [Parkinson's disease](/diseases/parkinsons-disease) (PD), where quantitative assessment of motor symptoms is critical for disease monitoring and therapeutic evaluation["@schlachetzki2017"].
Company History
Founding and Early Development
APDM was founded to address the need for objective, quantitative measures of human movement in clinical settings. The company's founding team brought together expertise in biomedical engineering, neuroscience, and clinical neurology.
The development of the Opal wearable sensor system represented a breakthrough in making laboratory-quality motion analysis accessible outside traditional motion capture laboratories. Prior to APDM's innovations, comprehensive gait analysis required expensive video-based systems available only in major research hospitals.
Movella Acquisition (2022)
In 2022, APDM was acquired by Movella, a company specializing in sensors and software for movement analysis across healthcare, entertainment, and industrial applications. The acquisition positioned APDM's technology within a broader portfolio of motion sensing solutions, enabling continued investment in research and product development.
Products and Technology
Opal Sensors
APDM's Opal wearable sensors are FDA-registered medical devices designed for quantitative movement analysis. The sensors are worn on the body (typically on the feet, ankles, wrists, and trunk) and capture motion data during various movement tasks[@godinho2016].
Technical Specifications
| Feature | Specification |
|---------|---------------|
| Sensor Type | Inertial Measurement Unit (IMU) |
| Components | 3-axis accelerometer, 3-axis gyroscope, 3-axis magnetometer |
| Sampling Rate | 128 Hz |
| Connectivity | Wireless Bluetooth |
| Battery Life | Up to 8 hours continuous recording |
| Weight | Approximately 25 grams per sensor |
| Dimensions | 45mm × 30mm × 15mm |
| Memory | Onboard SD card for standalone recording |
Sensor Placement Protocol
The standard APDM protocol involves placing sensors on:
- Lumbar spine (1 sensor) — for overall body movement and postural sway
- bilateral feet (2 sensors) — for gait timing and foot placement
- bilateral ankles (2 sensors) — for ankle movement during stance and swing
- bilateral thighs (2 sensors) — for thigh swing angle
- bilateral shanks (2 sensors) — for shank orientation
- bilateral wrists (2 sensors) — for arm swing analysis
This comprehensive placement enables calculation of over 200 distinct gait parameters, making it one of the most detailed wearable gait analysis systems available.
Mobility Lab Software
Mobility Lab is APDM's proprietary software platform that integrates with Opal sensors to provide automated analysis. The software automatically extracts key gait parameters without requiring manual processing[@horak2016].
Key Features
- Automated gait event detection — identifies heel strikes, toe-offs, and swing phases
- Spatiotemporal gait analysis — measures step length, step time, swing time, stance time
- Postural sway assessment — quantifies center-of-mass movement during quiet standing
- Timed Up and Go (TUG) — automated timing and analysis of this clinical test
- Sit-to-stand transfers — analyzes functional mobility
- Free-living monitoring — can analyze movement patterns during daily activities
- Turn analysis — quantifies turning behavior (turn duration, number of steps)
Output Parameters
The software generates comprehensive reports including:
- Gait velocity and cadence
- Step and stride length
- Variability indices (step time variability, swing time variability)
- Symmetry metrics
- Postural sway metrics (range, velocity, area)
- Fall risk scores
Clinical Applications
APDM systems are used extensively in clinical research and patient care for:
Parkinson's Disease
APDM technology has become particularly valuable in [Parkinson's disease](/diseases/parkinsons-disease) research and clinical care[@moccia2020]:
- Motor symptom quantification — objective measurement of bradykinesia, rigidity, and tremor
- Disease progression monitoring — tracking changes in gait and balance over time
- Treatment response evaluation — assessing the effects of dopaminergic medications
- Freezing of gait detection — identifying episodes where patients suddenly cannot initiate movement
- Fall risk assessment — identifying patients at increased risk of falls
Multiple Sclerosis
The system is used to monitor:
- Gait dysfunction patterns specific to MS
- Fatigue-related changes in walking
- Treatment effects on motor function
Stroke Rehabilitation
APDM supports rehabilitation by:
- Tracking recovery of gait function post-stroke
- Quantifying asymmetries in walking patterns
- Monitoring balance recovery
Geriatric Medicine
In elderly populations, APDM enables:
- Early identification of mobility decline
- Fall risk stratification
- Monitoring effectiveness of balance training programs
Clinical Trials
APDM technology is increasingly used as an objective endpoint in clinical trials for neurological disorders, providing:
- Objective, quantifiable outcome measures
- Continuous monitoring capabilities
- Reduced reliance on subjective clinical ratings
Clinical Validation
APDM technology has been extensively validated in peer-reviewed research, demonstrating:
Reliability
- High intrarater and interrater reliability for key gait parameters
- Excellent test-retest stability for repeated measurements
- Consistent performance across different testing environments[@mancini2017]
Validity
- Strong correlation with gold-standard motion capture systems (optical tracking)
- Accurate measurement of spatial and temporal gait parameters
- Valid measurement of postural sway metrics[@godinho2016]
Clinical Utility
- Sensitive to Parkinson's disease motor fluctuations
- Capable of detecting subtle changes in disease severity
- Useful for monitoring disease progression over time[@schlachetzki2017]
Research Impact
APDM technology has contributed to numerous research publications advancing understanding of movement disorders. The system enables researchers to:
- Collect objective data in natural environments, not just laboratory settings
- Perform continuous monitoring rather than snapshot assessments
- Analyze large cohorts efficiently with automated data processing
- Standardize measurement protocols across research sites
See Also
- [Parkinson's Disease - Wearables](/diseases/parkinsons-disease#wearables)](/proteins/parkin)
- [Parkinson's Disease - Digital Health Monitoring](/diseases/parkinsons-disease#digital-health)](/proteins/parkin)
- [Great Lakes NeuroTechnologies](/companies/great-lakes-neurotechnologies)](/technologies)
- [PD Neurotechnology](/companies/pd-neurotechnology)](/companies/pd-neurotechnology)
- [Wearables in Neurodegeneration](/companies/wearables-neurodegeneration)
References
[Mancini M, et al., Validation of APDM mobility lab against gold standard motion capture (2017)](https://pubmed.ncbi.nlm.nih.gov/28255908/)
[Schlachetzki JC, et al., Wearable sensors in Parkinson's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28632447/)
[Godinho C, et al., Quantitative gait analysis in Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/26872141/)
[Horak FB, et al., Balance and gait correlation in Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27506371/)
[Moccia M, et al., Validation of wearable sensors for Parkinson's disease motor assessment (2020)](https://pubmed.ncbi.nlm.nih.gov/33145678/)
[Movella Holdings Inc. - APDM Integration (2023)](https://investors.movella.com/)Pathway Diagram
The following diagram shows the key molecular relationships involving APDM (Mobility Lab) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)